Bluejay Diagnostics Inc. (NASDAQ: BJDX)
$0.57
-0.0005 ( -0.09% ) 254.8K
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
Market Data
Open
$0.57
Previous close
$0.57
Volume
254.8K
Market cap
$3.40M
Day range
$0.55 - $0.59
52 week range
$0.53 - $111.84
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Oct 02, 2023 |
8-k | 8K-related | 18 | Aug 28, 2023 |
8-k | 8K-related | 14 | Aug 16, 2023 |
10-q | Quarterly Reports | 64 | Aug 14, 2023 |
8-k | 8K-related | 14 | Aug 10, 2023 |
8-k | 8K-related | 15 | Jul 21, 2023 |